Wendy L. Davis

Wendy Davis is the Founder and CEO of GestVision, Inc. Wendy has over 30 years of experience in biotechnology, cultivating novel opportunities from early-stage inventions through commercialization and, where appropriate, FDA approval.

Before founding GestVision, Wendy held positions at HistoRx, Inc, a biotechnology company delivering diagnostic solutions to guide treatment decisions in oncology (acquired by Novartis), Curagen Corporation, the University of South Florida Moffitt Cancer Center and Cytogen Corporation.

Wendy holds an MBA from Yale University and a BA from Swarthmore College.